Medical Oncology
Chandra P. Belani, MD, is Professor of Medicine in the Division of Hematology/Oncology of the Department of Medicine at the University of Pittsburgh School of Medicine. He serves as Co-Program Leader of the UPCI Lung and Thoracic Malignancies Program, and also directs the Clinical Core for the Lung Cancer SPORE. He has been recognized as one of America's Top Doctors and Best Doctors year after year.
Dr. Belani is internationally renowned for his accomplishments in the area of lung cancer therapeutics and new drug development, and has received multiple awards for his work. His research efforts have led to changes in treatment paradigms for lung cancer. Dr. Belani has chaired several national and international trials testing novel prevention, drug development and treatment strategies for lung cancer. He plays a key strategic role in moving promising new discoveries from the laboratory to the clinic and serves as a leader for early phase clinical trials program at the UPCI. Dr. Belani interacts closely with other lung cancer experts across the world to develop and identify new therapeutic strategies to improve efficacy of interventions for the prevention and treatment of lung and thoracic malignancies. He is also the Editor-in-Chief of the journal Clinical Lung Cancer, and has extensively contributed to the literature on Lung Cancer and New Drug Development.
